WuXi PharmaTech: How to Argue for a Few Dollars More
WuXi PharmaTech's recent placements of stock of its NEEQ-listed Syn-The-All Pharmaceutical Co. subsidiary have been at a substantially higher...
412 Views
Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder
China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...
379 Views
China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
430 Views
WuXi's Chairman and Ally Bridge Offer $46/ADS in Going Private Bid
WuXi's Founder, Chairman and CEO, Dr. Ge Li and private equity firm Ally Bridge have made a non-binding offer to take the company private for...
586 Views
Increasing Opportunities in Emerging Market CROs
Life sciences R&D spending growth in Asia is outpacing the developed world (US, Canada, and Europe). An article from the January 2, 2014,...
330 Views